Home
›
Videos
›
Dermbits
›
Boxed Warnings Evidence Associated Jak Inhibitors 22
Ruxolitinib has boxed warnings. What’s the evidence that it is associated with the same adverse events that appear on the boxed warnings for oral JAK inhibitors?
Featuring:
AG
Alexandra Golant, MD
Faculty
Updated:
Aug 18, 2026
Atopic Dermatitis